|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0205195,
umls-concept:C0221464,
umls-concept:C0336636,
umls-concept:C0574032,
umls-concept:C1512948,
umls-concept:C1517564,
umls-concept:C1533685,
umls-concept:C1548161,
umls-concept:C2239176
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-7-15
|
|
pubmed:abstractText |
Combination treatment consisting of hepatic arterial infusion chemotherapy with epirubicin and cisplatin (HAIC-EC) and systemic infusion of low-dose 5-fluorouracil (5-FU) are sometimes effective against advanced hepatocellular carcinoma (HCC). However, there is no effective treatment for advanced HCCs with arterioportal shunts (APS) or arteriovenous shunts (AVS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1738-222X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
120-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21757983-Aged,
pubmed-meshheading:21757983-Angiography,
pubmed-meshheading:21757983-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21757983-Carcinoma, Hepatocellular,
pubmed-meshheading:21757983-Cisplatin,
pubmed-meshheading:21757983-Epirubicin,
pubmed-meshheading:21757983-Fluorouracil,
pubmed-meshheading:21757983-Hepatic Artery,
pubmed-meshheading:21757983-Humans,
pubmed-meshheading:21757983-Infusions, Intra-Arterial,
pubmed-meshheading:21757983-Injections, Intramuscular,
pubmed-meshheading:21757983-Interferon-gamma,
pubmed-meshheading:21757983-Liver Neoplasms,
pubmed-meshheading:21757983-Male,
pubmed-meshheading:21757983-Recombinant Proteins,
pubmed-meshheading:21757983-Tomography, X-Ray Computed,
pubmed-meshheading:21757983-Tumor Burden
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results.
|
|
pubmed:affiliation |
Hepatology Center, Bundang Jesaeng General Hospital, Seongnam, Korea.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
